RecruitingNCT05080634

Analysis of Prevalence and Risk Factors Associated With Gastroesophageal Reflux Disease and Esophagitis After Peroral Endoscopic Myotomy

Analysis of Incidence and Risk Factors Associated With Gastroesophageal Reflux Disease and Esophagitis After Peroral Endoscopic Myotomy


Sponsor

Maria Sklodowska-Curie National Research Institute of Oncology

Enrollment

100 participants

Start Date

Jun 1, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

Achalasia is an uncommon disorder that results from the degeneration of ganglion cells of the myenteric plexus in the lower esophageal wall. Peroral endoscopic myotomy (POEM) is a minimally invasive procedure capable of overcoming limitations of achalasia treatments. This study aimed to: 1) identify the prevalence of reflux esophagitis and asymptomatic GERD in patients who underwent POEM, and 2) evaluate patient and intraprocedural variables associated with post-POEM GERD.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • Males and females who are 18 years of age and older and are willing to sign an Informed Consent Form (ICF)
  • Achalasia patients who underwent POEM

Exclusion Criteria2

  • Lack of written consent for participation in the study
  • Conditions which are contraindication to Esophagogastroscopy and High-resolution Esophageal Manometry

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERPatients who underwent POEM

chalasia patients were recruited from a single center. The pre- and postoperative assessments included Eckardt scores, GerdQ questionnaire, high-resolution esophageal manometry, esophagogastroscopy and pH monitoring.


Locations(1)

Maria Sklodowska-Curie Institute - Oncology Center

Warsaw, Poland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05080634


Related Trials